Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging Bioidentical Hormones - U.S. Senate Special Committee on Aging
2107 National Association of Boards of Phanracy Survey of Pharmacy Law XVI. Pharmacy Licensure Requirements (conl.) Footnotes () - canL 219 MN MO - Cuommuity/tesail, hospital, pneentmcaletmerau/home health care, long-entm care, nuclear, nonnesident. Community ambulatory, hospital outpatient, long-term care, nensertile cumpounding, cadiophattraceutical, renal dialysis. medical gac, setile product compounding, consultant services, shared services, and Internet. Controlled subtanoces regisuration is handled by another statr agency, oat the Board of Pharmeacy. MS Community, institutional, limited closed door, noaresidee. NC - Phurmacy pcmits, limited scerv permits, nut-of-state permits. ND - Outpatient, home health care, nuclear, NJ - NV - OH - out-of-state, research, hospital, lung-term care, mail order,. gvrenmental agency, office pmrtice, telephartnacy. Retail. hospstaiminstirohotl. Specraized permits where applicable. Retail. insntutional. Retail, hospital, long-term care, fluid therapy/home health care, clinic. HMO. mail order, nuclear, specialty. dumable OK - medical cqnip-n., charitabhl. Retail, hospital, nonresident, charuible. OR - Pharmacy categories include 'rtail with controllcd substances," 'retail without controlled substances." "istitutional without controlled substances." and "institutiunal with controlled subsrmaces." PR - Board issues licenses to pharmacies (commuainy and institutional), wholesalers, manufacturcs, nonpharmacy ovcr-th.-coumrer drug outlets, and drug deposis. RI - Retail (includes community, parmnicarl, nulclar), institutional (includes hospital, HMO, univcrsity, other setutngs). SD - Full time, part timc. TN - Community. hospital, numsing home, home health care, nuclear, other. TX - Commnity. nuclar, institutional, clinic, nonresident. UT - Class A: Retril; Class B: Instsiutional: Class C: Wholesaler (or-state): Class D: Out-of-Sbte Mail Ordes Class e: Other. VT - Retail. instituutional, research and in.osgtigtion, manufacturer. Wholesalers and nanrsident pharmtacies.
220 Roster of Board of Pharmacy Ececutivec 10 9000oCcooo S-n I1 2 15018050052.3 O Ao5sL. 4135242 205s/981.2252180 205/552-22J30 11602/op 0015 hb&..C~~~~~b..- 5071403.1.01270 217/782-85055r 4I7/702.7025 100700107001117100 20-0140010= 21~/-US~~10dr ALASKA INDl-AIN Sl lt~hilO uml~mg 570I3080001-55 998 1n800o 10 r I 100-0 .1 Ae104,1200I .1 0r 85O7/405-2095250rl7/20i5-2974 .Iooh 0,oomOOo IIIU01.9 =YM MUR Al b. r- 117018-Nm5220 4I2 W W _gs SI. r 072 ioioaos 0/485N04 2730D 00020 9p0,, 1. A1/00/7718110 517/534 200e75307(33.4230 p1.455. 10go 052501. 10d Wolod. e0150 - AII~~~~~~~~~xONA~~~~~~~~ 2221551 W o Soo 1 *40 08121 988s5302-O 3044 852/402.2772752523/32r0243 hIold4p.C. p I OWA Wsml. DU.. S3 .&. rPr-bb 0Jse h J2.0 050 1510 D10/Sory 2SW00 rSa. 5050 e.00 Solo IA s03sse8 515/25 I0o 50e42 r52500(01 .4000 0oed JO~oS~o 0015010101505010.81.2 101.82.0/000 ARICANSAN KANSAS Oh1.115 .1c7001098000 I700lo 0.50 000500o7X. 540111(03800127 501/r002-0150(r A 01/r0s20185 r5o 500700.05 hS012. 1231 c.LMOR .... 0.ouC/Y 1 0 0110002 o~y Ocosd. Ostollh 015ka7 (62501N0610711.5r N~Sroooo . 09000. A fi34 510/37750075c 1500/740310 141218 A r1550 57011 0002 550000114101N11112 850 550 302 2Q140011 0011 D00 115001..000311040 ngsl Itdols. Irr40511 COLOYADPO 0117://71181018-L 10 Wcody Arn10*9.1111 r Dblo (s5e-n 7.9527(38O. Damr. co0000255143 a355/05477040203a/754-7704 LOUISIANA M1. 0d. 1 3003 1020c20811 Olocl. Suob s. 0c1F osody 0047l550011500 58(00005 w 0.e.0 F. LA 47800-237 0050o 250.05 00 55/715017 00s/001004906,525/03558 1010.oohSdo(4117n, Ib ~ ~ ~ ~ ~ ~ ~ ~~~~~~D dT~a 005NS19 C OIAst~ 5050 0lodo F1400 047 On01400 Vc SFr 008711 r 14vrd 0078 DRrrr/ l 35 y S-tIzU Sbh 550/713.07052000/713-7222 201 A. 1o43 ddo~ol~ooo.b p400000553207/02.8699 r- 27/022 -8627 0 bub0nue00 61 =1 o o 5 3s/dop/sfl2/do ldd-I.p 001w708 8 1 0 0 1 0 0 2 0 0 D/ZSI ll l 21/764-470505410 /354.0207 1_dh100.850./ 010 02754-452116,32/739571 '0150 '0 11o11s044o.0 D 20s 01004500N000 2390C.02. o/71.' 118 1L/5S72r202/727-lM 1110o.o 40.10d0 6000 151011001010101n w0dda100.0011ol ' ILOR N80IOAN -. Fen.D 3 9 s 0 050/4.02 0/53-6M A021 8-0- 80 517335-0910 51207/731 2175 ..o 73r. 3u24 rhT33s4 0.800/.104805-1 6 1 1 2,.012500700 -1 3 2310992010010. GA001 30207-305 5/0 06851/200 203 -,--III -r ./,b p .P h W. L 470/7 000 (88470/207 C b5933 14o101800 41 s oM e lc -00100a 7001.40/11/01 280A7/as ljo hR 7.505-20. 0010/88NI 4001.08.0011100 L ~~,b p-, U 96932mPta AN S-od mols~s3 en nz x o s v4 1^r.014 114 0805201 013.0151 0002 phol0pr0mo.001b0 70053010115d44111805000IE320 071/735-7400=1 Ms K69 I~A 0152 U. 070/735.74033oo11090011p1158 e8 D 00191201.000o.. 01 8.42000' MOU.
- Page 171 and 172: 168 RISKS AND BENEFITS OF ESTROGEN
- Page 173 and 174: EFFECTS OF POSTMENOPAUSAL ESTIROGEN
- Page 175 and 176: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 177 and 178: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 179 and 180: pEyECTS OF POSTMENOPAUSAL ESTROGEN
- Page 181 and 182: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 183 and 184: EFFECTS OF POSTMENOPAUSAL ESTROGEN
- Page 185 and 186: 10000 isoor i I ea '° a wan 20-24
- Page 187 and 188: ~SDt~rpa g~2~Q ~ !~fm~. b~e ~ ng jh
- Page 189 and 190: Is associated with an Increased ris
- Page 191 and 192: 188 Postmenopausal hormone therapy
- Page 193 and 194: group (P= 04001), and In this subgr
- Page 195 and 196: Treatmnent recommendations Based on
- Page 197 and 198: 21.Grodsteln F. Manson JE, Colditz
- Page 199 and 200: _ ORWIGNAL CONTIuBUTION 196 Postmen
- Page 201 and 202: showed no striking differences in H
- Page 203 and 204: (214 cases; P for trend=.72): howev
- Page 205 and 206: 202 HORMONE THERAPY USE AND RISK OF
- Page 207 and 208: mal studies, and laboratory studies
- Page 209 and 210: 206 HORMONE THERAPY USE AND RISK OF
- Page 211 and 212: 208 HORMONE THERAPY USE AND RISK OF
- Page 213 and 214: 210 ,lmcCII na: CLI I tr: tarty ver
- Page 215 and 216: 212 ,mucmai rimi &ronos farty bstro
- Page 217 and 218: 214 LntIucwu miau: rronos nary estr
- Page 219 and 220: XVI. PNharmacy Licensure Requiremen
- Page 221: XVI. Pharmacy Licensure Requirement
- Page 225 and 226: 050. 0l7404405400 Al-h. PeVbU 03283
- Page 227 and 228: Conclusions * Age is a powerful ris
- Page 229 and 230: Women's Health Initiative Trials of
- Page 231 and 232: Hormone Therapy after WHI * Change
- Page 233 and 234: Statement of the American Pharmacis
- Page 235 and 236: 232 APhA Statement to the S
- Page 237 and 238: 234 APhA Statement to the S
- Page 239 and 240: 236 APhA Statement to the S
- Page 241 and 242: 238 APhA Statement to the S
- Page 243 and 244: 240 Written Testimony of Steven F.
- Page 245 and 246: 242 STATEMENT OF DAVID G. ADAMS On
- Page 247 and 248: 244 Report on State Laws and Regula
- Page 249 and 250: 246 Only one state, Utah, requires
- Page 251: 248 5. Compounding Copies of FDA-Ap
2107<br />
Nati<strong>on</strong>al Associati<strong>on</strong><br />
of Boards of Phanracy<br />
Survey of<br />
Pharmacy<br />
Law<br />
XVI. Pharmacy Licensure Requirements (c<strong>on</strong>l.)<br />
Footnotes () - canL<br />
219<br />
MN<br />
MO -<br />
Cuommuity/tesail, hospital, pneentmcaletmerau/home<br />
health care, l<strong>on</strong>g-entm care,<br />
nuclear, n<strong>on</strong>nesident.<br />
Community ambulatory, hospital<br />
outpatient, l<strong>on</strong>g-term care, nensertile<br />
cumpounding, cadiophattraceutical, renal<br />
dialysis. medical gac, setile product<br />
compounding, c<strong>on</strong>sultant services,<br />
shared services, and Internet. C<strong>on</strong>trolled<br />
subtanoces regisurati<strong>on</strong> is handled by<br />
another statr agency, oat the Board of<br />
Pharmeacy.<br />
MS Community, instituti<strong>on</strong>al, limited closed<br />
door, noaresidee.<br />
NC - Phurmacy pcmits, limited scerv<br />
permits, nut-of-state permits.<br />
ND - Outpatient, home health care, nuclear,<br />
NJ -<br />
NV -<br />
OH -<br />
out-of-state, research, hospital, lung-term<br />
care, mail order,. gvrenmental agency,<br />
office pmrtice, telephartnacy.<br />
Retail. hospstaiminstirohotl. Specraized<br />
permits where applicable.<br />
Retail. insntuti<strong>on</strong>al.<br />
Retail, hospital, l<strong>on</strong>g-term care, fluid<br />
therapy/home health care, clinic. HMO.<br />
mail order, nuclear, specialty. dumable<br />
OK -<br />
medical cqnip-n., charitabhl.<br />
Retail, hospital, n<strong>on</strong>resident, charuible.<br />
OR - Pharmacy categories include 'rtail<br />
with c<strong>on</strong>trollcd substances," 'retail<br />
without c<strong>on</strong>trolled substances."<br />
"istituti<strong>on</strong>al without c<strong>on</strong>trolled<br />
substances." and "institutiunal with<br />
c<strong>on</strong>trolled subsrmaces."<br />
PR - Board issues licenses to pharmacies<br />
(commuainy and instituti<strong>on</strong>al),<br />
wholesalers, manufacturcs, n<strong>on</strong>pharmacy<br />
ovcr-th.-coumrer drug<br />
outlets, and drug deposis.<br />
RI - Retail (includes community,<br />
parmnicarl, nulclar), instituti<strong>on</strong>al<br />
(includes hospital, HMO,<br />
univcrsity, other setutngs).<br />
SD - Full time, part timc.<br />
TN - Community. hospital, numsing<br />
home, home health care, nuclear,<br />
other.<br />
TX - Commnity. nuclar, instituti<strong>on</strong>al,<br />
clinic, n<strong>on</strong>resident.<br />
UT - Class A: Retril; Class B:<br />
Instsiuti<strong>on</strong>al: Class C: Wholesaler<br />
(or-state): Class D: Out-of-Sbte<br />
Mail Ordes Class e: Other.<br />
VT - Retail. instituuti<strong>on</strong>al, research<br />
and in.osgtigti<strong>on</strong>, manufacturer.<br />
Wholesalers and nanrsident<br />
pharmtacies.
Change language